Please use this identifier to cite or link to this item:
Title: Extended anticoagulation after venous thromboembolism: should it be done?
Authors: FERNANDES, Caio J.CALDERARO, DanielaPILOTO, BrunaHOETTE, SusanaJARDIM, Carlos Vianna PoyaresSOUZA, Rogerio
Citation: THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, v.13, article ID 1753466619878550, 13p, 2019
Abstract: Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of anticoagulation. Recurrence rates are high and potentially life-threatening. In these cases, it would make sense to prolong anticoagulation for an undetermined length of time. However, what about the bleeding rates, induced by prolonged anticoagulation? Would they not outweigh the benefit of reducing the VTE recurrent risk? How long should anticoagulation be continued, and should all patients suffering from VTE be provided with extended anticoagulation? This review will address the most recent data concerning extended anticoagulation in VTE secondary prophylaxis. The reviews of this paper are available via the supplementary material section.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCP
Departamento de Cardio-Pneumologia - FM/MCP

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/08
LIM/08 - Laboratório de Anestesiologia

Artigos e Materiais de Revistas Científicas - LIM/09
LIM/09 - Laboratório de Pneumologia

Files in This Item:
File Description SizeFormat 
art_FERNANDES_Extended_anticoagulation_after_venous_thromboembolism_should_it_be_2019.PDFpublishedVersion (English)379.77 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.